In triple-negative breast cancer cells, TRIB1 was one of only six genes upregulated in both MDA-MB-231 and HS578T paclitaxel-resistant cells, indicating it is likely essential in the development of paclitaxel resistance [77]. Here, TRIB1 is linked to triple-negative breast carcinoma.